ENDANGERED DATABASES
The US National Library of Medicine (NLM) is cutting resources that biologists say are vital to their research. Another option is to charge users, but Musen calls that "absurd", arguing that it would discourage scientists from accessing sites and, in the case of Protégé, from contributing the code and plug-ins that make it a useful resource. Musen wants to win funding from the NIH to keep Protégé going as a key component of new research projects. In June 2011, he submitted a grant application with more than 100 letters of support from scientists; reviewers acknowledged the letters but said that they had nothing to do with the grant's specific research goals, and turned it down. Musen resubmitted the application, and should learn the results this month.
Resource
Other databases are putting their trust in commercial sponsors. REBASE, which holds data on where enzymes bind to and cut DNA, is partially supported by laboratory-reagent company New England Biolabs of Ipswich, Massachusetts. When federal money runs out in 2014, the company will take on the full costs, says Richard Roberts, chief scientific officer of New England Biolabs and founder of REBASE. But he acknowledges that this potentially leaves the database at the mercy of shifting commercial priorities.
The least vulnerable databases are those directly run by government agencies, says Francis Ouellette, a bioinformatician at the Ontario Institute for Cancer Research in Toronto, Canada. Investigator-driven databases face more challenges because "they don't fit the research-based standard model" used to dispense grants. Cutting funding for poorly performing or obsolete databases is sensible, says Ouellette, but choking established sites that have significant user communities is "really short-sighted. If it's a good database it should be maintained. "
Florance argues that the NLM should back innovation, which is difficult when its funds are tied up in infrastructure. "I don't think anyone would say that because they got a grant and built a database, they should get money forever. "
One solution, says Musen, could be to wean successful projects off investigator-initiated grants and move them into the NIH's longerterm intramural programmes. But Botstein thinks that would require a philosophical change at the agency. "What's really required is an understanding of the larger problem, " he says. "This is a big thing, and it will be a big thing for years to come. " ■ IAU 6 S E P T E M B E R 2 0 1 2 | V O L 4 8 9 | N A T U R E | 1 9
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